Loading stock…

National HealthCare Corporation (NHC) Stock Verdict & Ratings | Investment Bastion

Stock Verdict·Updated 1d ago

National HealthCare Corporation

NHCMarket cap $3.46BPrice $221.2

Country🇺🇸United States

SectorHealthcare

IndustryHealthcare Services

Operates skilled nursing facilities, senior living communities, and rehabilitation services across the Southeast US. It's one of the largest publicly traded nursing home operators, betting big on America's aging population needing long-term care.

In Bastion Portfolios?

52W Return+83%Global Market +16%?

01Key Ratings

How does this stock score across Bastion factors?

Growth

Historical Revenue

Rev CAGR (3y)+12%7

Revenue Forecast

Rev CAGR (1y)+13%7

Rev CAGR (3y)+8%6

Rev CAGR (5y)+5%5

Earnings Forecast

EPS Growth Y+1+24%8

EPS Growth Y+2+19%8

EPS Growth Y+3+4%5

Quality

Margins

EBIT Margin9%4

Net Income Margin9%5

Free Cash Flow Margin9%6

Debt

Net Debt/EBITDA-0.810

Efficiency

ROE13%6

ROA9%8

Earnings Stability55

GEAR+STRONG75

Overall rating across all five factors

Value

Price Multiples

P/E Ratio (Forward)223

P/E Ratio (Forward 3y)193

P/BV3.15

EV Multiples

EV/EBITDA Fwd163

EV/EBIT Fwd214

Yield

Free Cash Flow Yield4.2%6

Dividend Yield1.2%4

Momentum

Short term

1 month return+0%8

3 month return+5%8

YTD return+63%10

Mid term

Price vs 52wHigh93%9

1 year return+87%10

Long term

3 year return+254%10

5 year return+272%9

Risk Shield

Price Risk

Beta0.48

Volatility33%6

Free Cash Flow

Free Cash Flow Margin9%6

Free Cash Flow Yield4.2%6

Quality

ROCE11%6

Earnings Stability55

Net Debt/EBITDA-0.810

02Growth

Is it actually growing, and how fast?

NHCNational HealthCare

Revenue FY25$1.5B

GROWTH RATING↗

AVERAGE59 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+12%7

Revenue, next 1Y+13%7

Revenue, next 3Y, CAGR+8%6

Revenue, next 5Y, CAGR+5%5

EARNINGS FORECAST▾SCORE

EPS growth, FY26E+24%8

EPS growth, FY27E+19%8

EPS growth, FY28E+4%5

GROWTH ASSESSMENT

STRENGTHS

Revenue grew 12%/yr over the last 3 years, ahead of 60% of companies worldwide.7/10

Earnings are set to grow faster than sales (EPS about 19%/yr vs revenue 8%/yr), so margins should widen.

WATCH

A mid-pack grower, ahead of 59% of companies worldwide.

Revenue is set to grow 8%/yr over the next 3 years, a little ahead of the market.6/10

Revenue grew 12%/yr over the last 3 years; forecasts see it cooling to 8%/yr.

Over five years revenue is set to grow 5%/yr, about average versus companies worldwide.5/10

WEAKNESSES

None flagged.

BOTTOM LINE

Maturing Grower

A middle-of-the-pack grower that is slowing. The one thing to watch: the pace is cooling.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

VERY STRONG96 / 100

SHORT-TERM RETURNS▾SCORE

1-month return+0%8

3-month return+5%8

YTD return+63%10

MID & LONG-TERM▾SCORE

% of 52-week high93%9

1-year return+87%10

3-year return+254%10

5-year return+272%9

MOMENTUM ASSESSMENT

STRENGTHS

Magnificent long-term results. Long-term holders have seen +254% over three years and +272% over five, ahead of 90% of the market.

It's up 87% over the past year, now 7% below its 52-week high. That is clearly ahead of the market.

Strong recent results. The stock is outperforming over the past month (+0%), over three months (+5%) and so far this year (+63%).

WATCH

None flagged.

WEAKNESSES

None flagged.

BOTTOM LINE

Momentum Leader

Short- and long-term returns both rank among the best globally, and the stock trades near its highs. The market is fully behind it — a core fit for momentum strategies.

04Value

Are you paying a fair price for it?

Stop guessing on National HealthCare Corporation. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Loading charts…

02Growth

Is it actually growing, and how fast?

NHCNational HealthCare

Revenue FY25$1.5B

GROWTH RATING↗

AVERAGE59 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+12%7

Revenue, next 1Y+13%7

Revenue, next 3Y, CAGR+8%6

Revenue, next 5Y, CAGR+5%5

EARNINGS FORECAST▾SCORE

EPS growth, FY26E+24%8

EPS growth, FY27E+19%8

EPS growth, FY28E+4%5

GROWTH ASSESSMENT

STRENGTHS

Revenue grew 12%/yr over the last 3 years, ahead of 60% of companies worldwide.7/10

Earnings are set to grow faster than sales (EPS about 19%/yr vs revenue 8%/yr), so margins should widen.

WATCH

A mid-pack grower, ahead of 59% of companies worldwide.

Revenue is set to grow 8%/yr over the next 3 years, a little ahead of the market.6/10

Revenue grew 12%/yr over the last 3 years; forecasts see it cooling to 8%/yr.

Over five years revenue is set to grow 5%/yr, about average versus companies worldwide.5/10

WEAKNESSES

None flagged.

BOTTOM LINE

Maturing Grower

A middle-of-the-pack grower that is slowing. The one thing to watch: the pace is cooling.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

VERY STRONG96 / 100

SHORT-TERM RETURNS▾SCORE

1-month return+0%8

3-month return+5%8

YTD return+63%10

MID & LONG-TERM▾SCORE

% of 52-week high93%9

1-year return+87%10

3-year return+254%10

5-year return+272%9

MOMENTUM ASSESSMENT

STRENGTHS

Magnificent long-term results. Long-term holders have seen +254% over three years and +272% over five, ahead of 90% of the market.

It's up 87% over the past year, now 7% below its 52-week high. That is clearly ahead of the market.

Strong recent results. The stock is outperforming over the past month (+0%), over three months (+5%) and so far this year (+63%).

WATCH

None flagged.

WEAKNESSES

None flagged.

BOTTOM LINE

Momentum Leader

Short- and long-term returns both rank among the best globally, and the stock trades near its highs. The market is fully behind it — a core fit for momentum strategies.

04Value

Are you paying a fair price for it?

Stop guessing on National HealthCare Corporation. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community